The results showed that the therapeutic efficacy and CEA level in the experimental group were significantly better than those in the control group, with statistical significance (P < 0.05), indicating that the radiotherapy combined with capecitabine can reduce the infiltration degree of tumor cells in patients. Here, CEACAM5 is linked to neoplasm.